Perspective Therapeutics (CATX) Net Margin (2010 - 2023)

Perspective Therapeutics has disclosed Net Margin across 14 years of filings, most recently posting 473.5% for Q4 2023.

• In Q4 2023, Net Margin changed N/A year-over-year to 473.5%; the TTM figure through Dec 2023 stood at 3411.02% (changed N/A YoY), while the FY2023 annual figure was 3411.02%, changed N/A from the prior year.
• Net Margin came in at 473.5% for Q4 2023 at Perspective Therapeutics, up from 509.84% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 473.5% in Q4 2023 to a low of 609.48% in Q2 2023.
• Average Net Margin over 5 years is 77.2%, with a median of 46.29% recorded in 2022.
• Year-over-year, Net Margin jumped 9022 bps in 2019 and sank 57111 bps in 2023.
• Over 5 years, Net Margin stood at 40.75% in 2019, then climbed by 10 bps to 36.8% in 2020, then sank by 55 bps to 56.96% in 2021, then tumbled by 84 bps to 105.06% in 2022, then soared by 551 bps to 473.5% in 2023.
• Per Business Quant data, the three most recent Net Margin figures were 473.5% in Q4 2023, 509.84% in Q3 2023, and 609.48% in Q2 2023.